Business
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company,
About this update from Cardio Diagnostics Holdings Inc.
[{"type":"text","content":" CHICAGO--(BUSINESS WIRE)--\nCardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. Damon Broyles, MD, the VP of Clinical Innovation at Mercy Technology Services (MTS), the technical support arm of Mercy Healthcare, has joined Cardio Diagnostics as a strategic advisor.\n\nStrategic advisors at Cardio Diagnostics are pivotal in providing guidance and counsel to the management team. Dr. Broyles will leverage his extensive experience and knowledge in the healthcare industry to collaborate closely with the team to navigate complex challenges and capitalize on emerging opportunities in the dynamic cardiovascular disease, precision medicine, and innovation landscapes.\n\nIn his current role as the VP of Clinical Innovation at MTS, Dr. Broyles leads the charge on clinical innovation initiatives. He also serves as the Medical Director for the Multi-Cancer Early Detection program, emphasizing his dedication to cutting-edge solutions in healthcare. Dr. Broyles is a key figure in the development of Mercy's Department of Precision Medicine. He serves as an informatics facilitator and innovator for both MTS and Mercy, where he is responsible for driving value-based population health initiatives, including one of the nation's largest Accountable Care Organizations (ACOs). His exceptional leadership and strategic vision have played an integral role in the growth and success of the organization.\n\n\"I am thrilled to join Cardio Diagnostics and contribute my expertise in healthcare innovation and precision medicine,\" says Dr. Damon Broyles, VP of Clinical Innovation at Mercy Technology Services. \"As a strategic advisor, I am eager to collaborate with the team to drive innovation in the cardiovascular disease landscape. With the power of artificial intelligence and precision medicine, I believe that Cardio Diagnostics is poised to transform the field of cardiovascular medicine and improve patient outcomes on a global scale. I look forward to playing a role in advancing this mission and making a meaningful impact in the lives of patients and clinicians.\"\n\nDr. Broyles has developed a broad and expansive lens of the healthcare industry through a wide array of board appointments and advisory services for large technology firms, dynamic startups, and VC a...